View in EDS

WS15.03 Elexacaftor/tezacaftor/ivacaftor population pharmacokinetics in paediatric patients with cystic fibrosis.

Saved in:
Bibliographic Details
Title: WS15.03 Elexacaftor/tezacaftor/ivacaftor population pharmacokinetics in paediatric patients with cystic fibrosis.
Authors: Truong, N.H.1 (AUTHOR), Benaboud, S.2 (AUTHOR), Bardin, E.3 (AUTHOR), Miralles, M.2 (AUTHOR), Lui, G.2 (AUTHOR), Froelicher-Bournaud, L.2 (AUTHOR), Rouillon, S.2 (AUTHOR), Bouazza, N.1 (AUTHOR), Stremler, N.4 (AUTHOR), Bihouee, T.5 (AUTHOR), Bessaci-Kabouya, K.6 (AUTHOR), Coirier-Duet, E.7 (AUTHOR), Marguet, C.8 (AUTHOR), Deneuville, E.9 (AUTHOR), Laurans, M.10 (AUTHOR), Reix, P.11 (AUTHOR), Gerardin, M.12 (AUTHOR), Mittaine, M.13 (AUTHOR), Epaud, R.14 (AUTHOR), Thumerelle, C.15 (AUTHOR)
Source: Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS28-S28. 1p.
Database: Academic Search Ultimate
Description
ISSN:15691993
DOI:10.1016/S1569-1993(24)00195-4